Report of Mail Order Transactions

Forms and Documents

Document	Type	Status	Availability
1117-0033_Supporting Statement 2025 FINAL.docx	Supporting Statement A	Uploaded 2025-11-17	Repair queued
1117-0033_Supporting Statement 2025 FINAL.docx	Supporting Statement A	Uploaded 2025-11-17	Repair queued
Mail Order e-Report.xls	Supplementary Document	Uploaded 2019-05-16	Repair queued
Mail Order e-Report.xls	Supplementary Document	Uploaded 2019-05-16	Repair queued
21 USC 830.pdf	Supplementary Document	Uploaded 2019-05-06	Repair queued
21 USC 830.pdf	Supplementary Document	Uploaded 2019-05-06	Repair queued

IC Document Collections

IC ID	Collection	Type	Status	Form
12336	Report of Mail Order Transactions		Modified

ICR Details

OMB Control No: 1117-0033	ICR Reference No: 202511-1117-002
Status: Active	Previous ICR Reference No: 202207-1117-002
Agency/Subagency: DOJ/DEA	Agency Tracking No:
Title: Report of Mail Order Transactions
Type of Information Collection: Extension without change of a currently approved collection	Common Form ICR:  No
Type of Review Request: Regular
OIRA Conclusion Action: Approved without change	Conclusion Date: 01/16/2026
Retrieve Notice of Action (NOA)	Date Received in OIRA: 11/24/2025
Terms of Clearance: In accordance with 5 CFR 1320, this information collection is approved

	Inventory as of this Action	Requested	Previously Approved
Expiration Date	01/31/2029	36 Months From Approved	01/31/2026
Responses	216	0	264
Time Burden (Hours)	216	0	264
Cost Burden (Dollars)	0	0	23,705

---

Abstract: The Drug Enforcement Administration collects information regarding mail order transactions conducted between a person regulated by the agency and a nonregulated person (that is, someone who does not further distribute the product) involving the chemicals ephedrine, pseudoephedrine, and phenylpropanolamine. Transactions must use, or attempt to use, the United States Postal Service or any private or commercial carrier. This collection of information is mandated by 21 U.S.C. 830(b)(3), and permits the agency to monitor the distribution of ephedrine, pseudoephedrine and phenylpropanolamine, chemicals which are subject to diversion for the illicit manufacture of methamphetamine.

---

Authorizing Statute(s): US Code: 21 USC 830(b)(3) Name of Law: Controlled Substances Act
  

Citations for New Statutory Requirements: None

---

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:
	Not associated with rulemaking

---

Federal Register Notices & Comments
60-day Notice:	Federal Register Citation:	Citation Date:
	90 FR 42986	09/05/2025
30-day Notice:	Federal Register Citation:	Citation Date:
	90 FR 51794	11/18/2025
Did the Agency receive public comments on this ICR? No

---

Number of Information Collection (IC) in this ICR: 1

IC Title	Form No.	Form Name
Report of Mail Order Transactions

---

ICR Summary of Burden

	Total Approved	Previously Approved	Change Due to New Statute	Change Due to Agency Discretion	Change Due to Adjustment in Estimate	Change Due to Potential Violation of the PRA
Annual Number of Responses	216	264	0	-48	0	0
Annual Time Burden (Hours)	216	264	0	-48	0	0
Annual Cost Burden (Dollars)	0	23,705	0	-23,705	0	0

Burden increases because of Program Change due to Agency Discretion: No

Burden Increase Due to:

Burden decreases because of Program Change due to Agency Discretion: Yes

Burden Reduction Due to: Miscellaneous Actions

Short Statement: Changes to the annual responses and annual burden hours reflect a change in the number of annual respondents. Changes to the annual cost reflect change in methods. Previously, the approved 2022 figure represented the “Monetized Value of Respondent Time” calculated in section 12 of the Supporting Statement. The new requested annual cost represents the figure from section 13 of the Supporting Statement. There have been no statutory or regulatory changes affecting this information collection. The table in Section 15 of the Supporting Statement summarizes the changes since the last renewal of this information collection.

---

Annual Cost to Federal Government: $55,449

Does this IC contain surveys, censuses, or employ statistical methods? No

Does this ICR request any personally identifiable information (see OMB Circular No. A-130 for an explanation of this term)? Please consult with your agency's privacy program when making this determination.     No

Does this ICR include a form that requires a Privacy Act Statement (see 5 U.S.C. §552a(e)(3))? Please consult with your agency's privacy program when making this determination.     No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? No

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? No

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? No

Is this ICR related to the Pandemic Response? No

---

Common Form ICR:  No

---

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).

The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:

(a) It is necessary for the proper performance of agency functions;

(b) It avoids unnecessary duplication;

(c) It reduces burden on small entities;

(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;

(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;

(f) It indicates the retention periods for recordkeeping requirements;

(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:

(i) Why the information is being collected;

(ii) Use of information;

(iii) Burden estimate;

(iv) Nature of response (voluntary, required for a benefit, or mandatory);

(v) Nature and extent of confidentiality; and

(vi) Need to display currently valid OMB control number;

(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.

(i) It uses effective and efficient statistical survey methodology (if applicable); and

(j) It makes appropriate use of information technology.

If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.

Certification Date: 11/24/2025

---